Buck Institute’s Eric Verdin joins clinic leaders to tackle the ‘luxury diagnostic’ trap and the push for standardized care.
Shmouni and Koehl Robinson unpack peptide medicine, from GLP-1s and BPC-157 to evidence, safety, regulation and personalized ...
BodySpec’s new storefront targets muscle loss from GLP-1 weight loss drugs, with scans said to take about 12 minutes.
VectorY is growing PIONEER-ALS from 12 to 36 participants to test VTx-002, an antibody therapy aimed at the protein TDP-43.
A Censuswide survey commissioned by PortionIQ finds confidence is lower among longer-term users, though it’s a snapshot from one brand.
Forget the diagnosis count. The researcher who helped the WHO reframe aging says function, not disease, is the better yardstick.
A new preprint links the company’s cell therapy to less brain inflammation in Alzheimer’s, just as it heads out on an ...
The whole-body scan company is launching a research network with 50+ institutions. Early findings come with some big open ...
The company added hormone therapy to its platform and released IBS results from nearly 16,000 members, with caveats attached. Digbi Health has spent years collecting data on people’s guts. This week ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results